Feb 13 (Reuters)- Cosmo Bio Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Dec 31, 2025 Dec 31, 2024 Dec 31, 2026 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 10.77 10.04 11.40 5.70 (+7.3 pct) (+7.5 pct) (+5.9 pct) (+5.5 pct) Operating 343 mln 318 mln 270 mln 170 mln (+7.7 pct) (-38.7 pct) (-21.3 pct) (-38.5 pct) Recurring 489 mln 364 mln 340 mln 200 mln (+34.4 pct) (-44.2 pct) (-30.5 pct) (-41.7 pct) Net Net 337 mln 262 mln 220 mln 130 mln (+28.6 pct) (-40.8 pct) (-34.7 pct) (-48.2 pct) EPS 59.26 yen 45.05 yen 38.77 yen 22.91 yen Ann Div 50.00 yen 50.00 yen 50.00 yen -Q2 Div 25.00 yen 14.00 yen 25.00 yen -Q4 Div 25.00 yen 36.00 yen 25.00 yen NOTE - Cosmo Bio Co Ltd. *Second Net profit row denotes profit attributable to owners ofthe parent To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T